The Scientific Reporters

Exploring Science

News

No stones being unturned: Fluoxetine to disrupt viral replication in COVID-19 affected patients.

German experts speculate that Fluoxetine- an antidepressant drug can potentially reduce the viral replication in COVID-19 patients. Here’s more… The current COVID-19 pandemic has brought about unparalleled times for humanity. The measures taken to contain the virus have triggered a…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Asymptomatic COVID-19 transmission is very rare says WHO: A myth or truth?

With COVID-19 showing no mercy, and the number of confirmed cases increasing around the world, it is important to find the truth behind the transmission of asymptomatic cases. As the number of COVID-19 cases rising every day, it is important…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Respiratory failure during COVID-19 could be linked to certain genetic variants

Using data from genome-wide association study, experts speculate that gene variants encoding blood types and a multidisciplinary chromosome 3 could be the reason behind respiratory failure during COVID-19. Though it’s been several months since its first case, COVID-19 still manages…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

COVID19: AstraZeneca & Serum Institute of India collaborate to sign a deal for 1 billion doses of the novel Oxford University vaccine

The new Oxford University vaccine AZD 1222 shows promising results in COVID-19 patients. A deal signed by AstraZeneca and Serum Institute of India promises a billion doses of the vaccine for middle and low-income countries. With COVID-19 claiming its share…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

COVID-19: Can a novel flu drug be the breakthrough we all need?

With certain COVID-19 symptoms resembling the common flu, experts wonder if a new anti-flu drug- Baloxavir may be the solution we have all been waiting for.  The entire world is currently battling against COVID-19, as the number of confirmed cases…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Premas biotech announced the completion of their vaccine prototype against COVID-19.

With the race against COVID-19 building tension among the healthcare sector, India based biotech company, Prema Biotech announces successful completion of their vaccine prototype against COVID-19 using inhouse D-crypt technology. With COVID-19 infecting millions and claiming over 300,00 lives all…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

A much-needed discovery: Scientists find a way to infect mice with COVID-19

The novel COVID-19 though effective in spreading among humans is not capable of the same in mice. Being a go-to model for studying diseases and developing treatments, scientists find a way to use CRISPR/Cas9 to infect the mice with COVID-19…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Can Riboflavin & UV light reduce COVID-19 pathogens in blood?

The recent outbreak of the novel virus COVID-19 has been termed a pandemic by the WHO. Although the disease is known to spread from person to person through air droplets, the virus still manages to surprise scientists every day. New…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Study reveals Cats are also susceptible to COVID-19

Beware pets! A study reveals that cats are susceptible to COVID-19, and are reported to be highly contagious.  New reports reveal that cats, just like humans are also susceptible to the highly contagious novel virus- COVID-19. Two studies conducted in…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

A faulty dementia gene poses a high risk of severe COVID-19

A faulty gene already known to increase the risk of developing Alzheimer’s now poses the risk of severe COVID-19. 5 months since the first outbreak, COVID-19 still never fails to surprise. With the novel virus claiming over 5 million lives…

Share
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •